NO20033144L - Modul¶re transfeksjonssystemer - Google Patents
Modul¶re transfeksjonssystemerInfo
- Publication number
- NO20033144L NO20033144L NO20033144A NO20033144A NO20033144L NO 20033144 L NO20033144 L NO 20033144L NO 20033144 A NO20033144 A NO 20033144A NO 20033144 A NO20033144 A NO 20033144A NO 20033144 L NO20033144 L NO 20033144L
- Authority
- NO
- Norway
- Prior art keywords
- transfection
- protein
- modified
- present
- relates
- Prior art date
Links
- 238000001890 transfection Methods 0.000 title abstract 7
- 108090000623 proteins and genes Proteins 0.000 abstract 5
- 102000004169 proteins and genes Human genes 0.000 abstract 4
- 102000011931 Nucleoproteins Human genes 0.000 abstract 3
- 108010061100 Nucleoproteins Proteins 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000035118 modified proteins Human genes 0.000 abstract 1
- 108091005573 modified proteins Proteins 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Fluid-Driven Valves (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Reciprocating, Oscillating Or Vibrating Motors (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10100996 | 2001-01-10 | ||
| PCT/DE2002/000060 WO2002055721A2 (fr) | 2001-01-10 | 2002-01-10 | Systemes de transfection modulaires |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20033144D0 NO20033144D0 (no) | 2003-07-09 |
| NO20033144L true NO20033144L (no) | 2003-09-01 |
Family
ID=7670249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20033144A NO20033144L (no) | 2001-01-10 | 2003-07-09 | Modul¶re transfeksjonssystemer |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7320859B2 (fr) |
| EP (1) | EP1427837B1 (fr) |
| JP (2) | JP4551058B2 (fr) |
| KR (1) | KR100912741B1 (fr) |
| CN (1) | CN100510087C (fr) |
| AT (1) | ATE530659T1 (fr) |
| AU (1) | AU2002238376B2 (fr) |
| CA (1) | CA2434402A1 (fr) |
| DE (1) | DE10290072D2 (fr) |
| IL (1) | IL156780A0 (fr) |
| NO (1) | NO20033144L (fr) |
| WO (1) | WO2002055721A2 (fr) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8507277B2 (en) | 2003-10-24 | 2013-08-13 | Gencia Corporation | Nonviral vectors for delivering polynucleotides |
| JP4838722B2 (ja) | 2003-10-24 | 2011-12-14 | ゲンシア コーポレーション | ポリヌクレオチドを送達する方法、及び送達用組成物 |
| US8133733B2 (en) | 2003-10-24 | 2012-03-13 | Gencia Corporation | Nonviral vectors for delivering polynucleotides to target tissues |
| US20090123468A1 (en) | 2003-10-24 | 2009-05-14 | Gencia Corporation | Transducible polypeptides for modifying metabolism |
| US8062891B2 (en) | 2003-10-24 | 2011-11-22 | Gencia Corporation | Nonviral vectors for delivering polynucleotides to plants |
| WO2009067216A1 (fr) * | 2007-11-20 | 2009-05-28 | Beth Israel Deaconess Medical Center | Réactif de transfection |
| KR200453773Y1 (ko) * | 2008-07-07 | 2011-05-27 | 류선영 | 다용도 일회용 냅킨 |
| EP2208778A1 (fr) | 2009-01-20 | 2010-07-21 | Lonza Cologne AG | Procédé et dispositif destinés au traitement électrique d'espaces de réaction |
| CA2793959C (fr) | 2010-03-25 | 2019-06-04 | Oregon Health & Science University | Glycoproteines du cmv et vecteurs recombines |
| WO2012098260A1 (fr) | 2011-01-21 | 2012-07-26 | Axiogenesis Ag | Système non viral pour générer des cellules souches pluripotentes induites (ips) |
| PT2691530T (pt) | 2011-06-10 | 2018-05-10 | Univ Oregon Health & Science | Glicoproteínas e vectores recombinantes cmv |
| EP2568289A3 (fr) | 2011-09-12 | 2013-04-03 | International AIDS Vaccine Initiative | Immunosélection du virus de la stomatite vésiculaire recombinant exprimant les protéines du VIH-1 par des anticorps largement neutralisants |
| EP2586461A1 (fr) | 2011-10-27 | 2013-05-01 | Christopher L. Parks | Particules virales dérivées d'un virus enveloppé |
| ES2631608T3 (es) | 2012-06-27 | 2017-09-01 | International Aids Vaccine Initiative | Variante de la glicoproteína Env del VIH-1 |
| US20150065381A1 (en) | 2013-09-05 | 2015-03-05 | International Aids Vaccine Initiative | Methods of identifying novel hiv-1 immunogens |
| EP2873423B1 (fr) | 2013-10-07 | 2017-05-31 | International Aids Vaccine Initiative | Trimères de glycoprotéines d'enveloppe du vih -1 soluble |
| US10174292B2 (en) | 2015-03-20 | 2019-01-08 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
| US9931394B2 (en) | 2015-03-23 | 2018-04-03 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
| US9925258B2 (en) | 2015-10-02 | 2018-03-27 | International Aids Vaccine Initiative | Replication-competent VSV-HIV Env vaccines |
| CA3028074A1 (fr) | 2016-06-16 | 2018-12-20 | Oslo Universitetssykehus Hf | Edition de gene amelioree |
| TW201932478A (zh) * | 2017-10-12 | 2019-08-16 | 美國馬友醫藥教育研究基金會 | 用於基因編輯的方法和材料 |
| EP3794132A1 (fr) | 2018-05-18 | 2021-03-24 | F. Hoffmann-La Roche AG | Administration intracellulaire ciblée de grands acides nucléiques |
| CN117305360B (zh) * | 2023-09-15 | 2024-09-24 | 江南大学 | 一种哺乳动物细胞核转染液及其制备方法和在细胞核内递送的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4950599A (en) | 1987-01-29 | 1990-08-21 | Wolf Bertling | Method for exchanging homologous DNA sequences in a cell using polyoma encapsulated DNA fragments |
| NZ244306A (en) * | 1991-09-30 | 1995-07-26 | Boehringer Ingelheim Int | Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation |
| US5763240A (en) | 1992-04-24 | 1998-06-09 | Sri International | In vivo homologous sequence targeting in eukaryotic cells |
| US5468629A (en) | 1993-04-13 | 1995-11-21 | Calhoun; Cornelia | Method of promoting in vitro homologous recombination transfection in mammalian cells using the RecA protein |
| US5807746A (en) | 1994-06-13 | 1998-09-15 | Vanderbilt University | Method for importing biologically active molecules into cells |
| US5948653A (en) * | 1997-03-21 | 1999-09-07 | Pati; Sushma | Sequence alterations using homologous recombination |
| IL143983A0 (en) | 1999-01-08 | 2002-04-21 | Amaxa Gmbh | Use of cellular transport systems for the transfer of nucleic acids through the nuclear envelope |
| WO2000058488A2 (fr) * | 1999-03-31 | 2000-10-05 | Invitrogen Corporation | Diffusion de sequences de proteines fonctionnelles par translocation de polypeptides |
| AU4657500A (en) | 1999-04-21 | 2000-11-02 | Pangene Corporation | Locked nucleic acid hybrids and methods of use |
| DE19925052B4 (de) * | 1999-06-01 | 2012-01-12 | Alexander Cherkasky | Proteinkomplexe für den zielgerichteten Transport von (Poly)Peptide und Nukleinsäuren und sequenzspezifische Integration von DNA-Vektoren |
-
2002
- 2002-01-10 CA CA002434402A patent/CA2434402A1/fr not_active Abandoned
- 2002-01-10 KR KR1020037009248A patent/KR100912741B1/ko not_active Expired - Fee Related
- 2002-01-10 JP JP2002556767A patent/JP4551058B2/ja not_active Expired - Fee Related
- 2002-01-10 EP EP02704571A patent/EP1427837B1/fr not_active Expired - Lifetime
- 2002-01-10 US US10/466,368 patent/US7320859B2/en not_active Expired - Fee Related
- 2002-01-10 DE DE10290072T patent/DE10290072D2/de not_active Expired - Fee Related
- 2002-01-10 WO PCT/DE2002/000060 patent/WO2002055721A2/fr not_active Ceased
- 2002-01-10 AU AU2002238376A patent/AU2002238376B2/en not_active Ceased
- 2002-01-10 IL IL15678002A patent/IL156780A0/xx unknown
- 2002-01-10 CN CNB028062205A patent/CN100510087C/zh not_active Expired - Fee Related
- 2002-01-10 AT AT02704571T patent/ATE530659T1/de active
-
2003
- 2003-07-09 NO NO20033144A patent/NO20033144L/no not_active Application Discontinuation
-
2007
- 2007-11-21 US US11/944,253 patent/US7999073B2/en not_active Expired - Fee Related
-
2008
- 2008-03-05 JP JP2008054910A patent/JP4697982B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002055721B1 (fr) | 2004-05-27 |
| JP2005505233A (ja) | 2005-02-24 |
| US7320859B2 (en) | 2008-01-22 |
| DE10290072D2 (de) | 2003-12-18 |
| ATE530659T1 (de) | 2011-11-15 |
| US7999073B2 (en) | 2011-08-16 |
| US20040137622A1 (en) | 2004-07-15 |
| WO2002055721A3 (fr) | 2004-04-15 |
| NO20033144D0 (no) | 2003-07-09 |
| JP2008200041A (ja) | 2008-09-04 |
| CN1529759A (zh) | 2004-09-15 |
| WO2002055721A2 (fr) | 2002-07-18 |
| EP1427837B1 (fr) | 2011-10-26 |
| AU2002238376B2 (en) | 2007-05-10 |
| CN100510087C (zh) | 2009-07-08 |
| JP4697982B2 (ja) | 2011-06-08 |
| JP4551058B2 (ja) | 2010-09-22 |
| US20080220527A1 (en) | 2008-09-11 |
| KR20030074702A (ko) | 2003-09-19 |
| EP1427837A2 (fr) | 2004-06-16 |
| CA2434402A1 (fr) | 2002-07-18 |
| KR100912741B1 (ko) | 2009-08-18 |
| IL156780A0 (en) | 2004-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20033144L (no) | Modul¶re transfeksjonssystemer | |
| IL158474A0 (en) | Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation | |
| BRPI0411112A (pt) | proteìna de fusão heteróloga, polinucleotìdeo, vetor, célula hospedeira, processo para produzir uma proteìna de fusão heteróloga, método para tratar um paciente, e, uso de proteìna de fusão heteróloga | |
| ATE443720T1 (de) | Fc-interferon-beta fusionsproteine | |
| DE60311567D1 (de) | Trizyklische pyrazolderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumor mittel | |
| DK1487416T3 (da) | Lægemiddelmikropartikler | |
| RU2004108061A (ru) | Способ лечения онкологических заболеваний | |
| BR0209658A (pt) | Derivados de 4-amino-5-fenil-7-1ciclobutil-pirrolo [2,3-d] pirimidina | |
| BG106106A (en) | Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma | |
| ATE264671T1 (de) | Verfahren für die in-vivo-verabreichung von biologischen substanzen und hierfür verwendbare zusammensetzungen | |
| DE60138468D1 (de) | Cyanophenoxy-carbonsäuren und zusammensetzungen für die freisetzung aktiver substanzen | |
| DE60203692D1 (de) | Latency associated peptide von tgf-beta um pharmazeutisch aktive proteine latent zu machen | |
| DK1175489T3 (da) | Oligonukleotider indeholdende en antisense-sekvens stabiliseret af en sekundær struktur og farmaceutiske præparater indeholdende disse oligonukleotider | |
| DE60215313D1 (de) | Indolderivate und deren verwendung als gnrh antagonisten | |
| DE60331574D1 (de) | Verfahren zur behandlung von erkrankungen mit mangel an thiolhaltiger verbindung | |
| WO2002007774A3 (fr) | Methodes de traitement de maladies neurodegeneratives du cerveau | |
| DE602005009978D1 (de) | Verfahren zur herstellung von zwei- und dreidimensionalen polymergerüsten | |
| DE60142899D1 (de) | Verbindungen für den transfer von oligonukleotiden | |
| BRPI0409683A (pt) | 5-hidroxiindóis com grupos n-óxido e seu emprego como agentes terapêuticos | |
| DE60115622D1 (de) | Methoden und zusammensetzungen zur aufklärung von proteinexpressionsprofilen in zellen | |
| DE60035504D1 (de) | Verfahren für die verabreichung von heilmitteln mittels einer dextrinlösung | |
| WO2000043510A3 (fr) | Molecules d'acides nucleiques et polypeptides d'activateurs de ras, et techniques d'emploi | |
| PT1032429E (pt) | Metodo para aplicacao de adn in vivo utilizando um aparelho sem agulha | |
| DE69941956D1 (de) | Contortrostatin(cn) sowie verfahren zu seiner verwr zustände | |
| WO2004009028A3 (fr) | Methodes et composition permettant de traiter et de prevenir l'infection grippale et les symptomes associes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |